Piramal Pharma Ltd.
PPLPHARMA Share PricePharmaceuticals & Drugs
₹198.94
-1.7 (-0.9%)
As on September 8, 2025
Exchange Scrips: BSE543635NSEPPLPHARMAISININE0DK501011
Market Cap ₹ 26,281 Cr
P/E Ratio 289.11
Dividend Yield 0.01 %
Performance
Market performance
Open202
High202
Volumes15,32,805
Prev198.94
Low198.5
As on2025-09-08
Historical performance
1 Year High307.9
3 Year High307.9
5 Year High307.9
1 Year Low181.73
3 Year Low61.62
5 Year Low61.62
Fundamentals
Company Valuation
Market Cap (₹Cr)
26,281
Face Value (₹)
10
P/E Ratio
289.11
Dividend Yield
0.01 %
Investment Returns
1 Year
-12.1%
3 Years
N/A
5 Years
N/A
10 Years
N/A
Technicals
| Indicators | Value | Signal |
|---|---|---|
| 5-DMA | 197.29 | Bullish |
| 10-DMA | 192.62 | Bullish |
| 20-DMA | 192.07 | Bullish |
| 50-DMA | 198.6 | Bullish |
| 100-DMA | 203.07 | Bearish |
| 200-DMA | 217.34 | Bearish |
Shareholding Pattern
| Field | Jun-2025 | Mar-2025 | Dec-2024 | Sep-2024 | Jun-2024 |
|---|---|---|---|---|---|
| Promoters | 17 | 17 | 17 | 17 | 17 |
| Foreign Investors | --- | --- | --- | --- | --- |
| Domestic Investors | 17 | 17 | 17 | 17 | 17 |
| Public Investors | 458413 | 432826 | 418425 | 359734 | 306381 |
| Government | 3 | 3 | 2 | 1 | 1 |
Financials
Below figures are in Rs. Crores
Balance Sheet
Below figures are in Rs. Crores
Cash Flow
Below figures are in Rs. Crores
0%
Negative
Neutral
Positive
- The stock has a PE ratio of 289.11.
- 3Y Stock Price CAGR of the stock is 3.5.
- The stock has a beta of 1.0.
- In the last financial year, the company had an EBITDA of ₹15796 Million.
- The company generated revenue of ₹91512 Million in the previous financial year.
Piramal Pharma Ltd.
198.94-1.7 (-0.9%)
₹
Investment Amount: ₹ 1000000
Current Value: ₹ 915340
No. of Shares: 4601 (Approx)
Performance:-8.5%
P/L: ₹-84660
Top Gainers
Peer Comparison
Get Your Portfolio Reviewed
Live video call With Our Agent